Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination

Background: Ipilimumab has proven to be effective in metastatic melanoma patients. The purpose of this study was to determine the efficacy of ipilimumab in advanced melanoma patients who showed progressive disease upon experimental dendritic cell (DC) vaccination. Methods: Retrospective analysis of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncoimmunology
Autores principales: Boudewijns, Steve, Koornstra, Rutger H. T., Westdorp, Harm, Schreibelt, Gerty, van den Eertwegh, Alfons J. M., Geukes Foppen, Marnix H., Haanen, John B., de Vries, I. Jolanda M., Figdor, Carl G., Bol, Kalijn F., Gerritsen, Winald R.
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2016
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5007966/
https://ncbi.nlm.nih.gov/pubmed/27622070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1201625
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares